Ib Jarle Christensen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Geographic Areas

Denmark

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Almasi Charlotte Elberling; Høyer-Hansen Gunilla; Christensen Ib Jarle; Pappot Helle
Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.
Jensen Trine O; Schmidt Henrik; Møller Holger Jon; Høyer Morten; Maniecki Maciej Bogdan; Sjoegren Pia; Christensen Ib Jarle; Steiniche Torben
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
Larsen Julie Mou; Christensen Ib Jarle; Nielsen Hans Jørgen; Hansen Ulla; Bjerregaard Bolette; Talts Jan Fredrik; Larsson Lars-Inge
Syncytin immunoreactivity in colorectal cancer: potential prognostic impact.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ib Jarle Christensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Almasi Charlotte Elberling; Høyer-Hansen Gunilla; Christensen Ib Jarle; Pappot Helle
Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2009;117(10):755-61.
2009: Jensen Trine O; Schmidt Henrik; Møller Holger Jon; Høyer Morten; Maniecki Maciej Bogdan; Sjoegren Pia; Christensen Ib Jarle; Steiniche Torben
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3330-7.
2009: Larsen Julie Mou; Christensen Ib Jarle; Nielsen Hans Jørgen; Hansen Ulla; Bjerregaard Bolette; Talts Jan Fredrik; Larsson Lars-Inge
Syncytin immunoreactivity in colorectal cancer: potential prognostic impact.
Cancer letters 2009;280(1):44-9.
2009: Frederiksen C; Lomholt A F; Davis G J; Dowell B L; Blankenstein M A; Christensen I J; Brünner N; Nielsen H J
Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
Anticancer research 2009;29(1):75-81.
2009: Høgdall Estrid V S; Ringsholt Merete; Høgdall Claus K; Christensen Ib Jarle; Johansen Julia S; Kjaer Susanne K; Blaakaer Jan; Ostenfeld-Møller Lene; Price Paul A; Christensen Lise H
YKL-40 tissue expression and plasma levels in patients with ovarian cancer.
BMC cancer 2009;9():8.
2008: Johansen Julia S; Lottenburger Tine; Nielsen Hans Jørgen; Jensen Jens Erik B; Svendsen Mads N; Kollerup Gine; Christensen Ib J
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(10):2603-8.
2008: Henic Emir; Borgfeldt Christer; Christensen Ib Jarle; Casslén Bertil; Høyer-Hansen Gunilla
Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5785-93.
2008: Bülow Steffen; Bülow Charlotte; Vasen Hans; Järvinen Heikki; Björk Jan; Christensen Ib Jarle
Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis.
Diseases of the colon and rectum 2008;51(9):1318-23.
2008: Gimsing Peter; Hansen Mads; Knudsen Lene M; Knoblauch P; Christensen Ib Jarle; Ooi Chean Eng; Buhl-Jensen Peter
A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia.
European journal of haematology 2008;81(3):170-6.
2008: Ytting Henriette; Christensen Ib Jarle; Thiel Steffen; Jensenius Jens Christian; Nielsen Hans Jørgen
Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer.
Human immunology 2008;69(7):414-20.
2008: Nøjgaard Camilla; Høst Nis B; Christensen Ib Jarle; Poulsen Steen Hvitfeldt; Egstrup Kenneth; Price Paul A; Johansen Julia S
Serum levels of YKL-40 increases in patients with acute myocardial infarction.
Coronary artery disease 2008;19(4):257-63.
2008: Roslind Anne; Johansen Julia S; Christensen Ib J; Kiss Katalin; Balslev Eva; Nielsen Dorte L; Bentzen Jens; Price Paul A; Andersen Elo
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
International journal of cancer. Journal international du cancer 2008;122(4):857-63.
2008: Knudsen Lene S; Christensen Ib J; Lottenburger Tine; Svendsen Mads N; Nielsen Hans J; Nielsen Lone; Hørslev-Petersen Kim; Jensen Jens E B; Kollerup Gina; Johansen Julia S
Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2008;13(1):59-78.
2008: Frederiksen C B; Lomholt A F; Lottenburger T; Davis G J; Dowell B L; Blankenstein M A; Christensen I J; Brunner N; Nielsen H J
Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.
The International journal of biological markers 2008;23(1):42-7.
2008: Schrohl Anne-Sofie; Mueller Volkmar; Christensen Ib Jarle; Pantel Klaus; Thomssen Christoph; Bruenner Nils
A comparative study of tissue inhibitor of metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(3):181-7.
2008: Dejligbjerg Marielle; Grauslund Morten; Christensen Ib Jarle; Tjørnelund Jette; Buhl Jensen Peter; Sehested Maxwell
Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines.
Cancer biomarkers : section A of Disease markers 2008;4(2):101-9.
2008: Talman Maj-Lis M; Rasmussen Birgitte B; Andersen Jørn; Christensen Ib J
Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications.
Acta oncologica (Stockholm, Sweden) 2008;47(4):789-94.
2008: Rasmussen Birgitte Bruun; Andersson Michael; Christensen Ib J; Møller Susanne
Evaluation of and quality assurance in HER2 analysis in breast carcinomas from patients registered in Danish Breast Cancer Group (DBCG) in the period of 2002-2006. A nationwide study including correlation between HER-2 status and other prognostic variables.
Acta oncologica (Stockholm, Sweden) 2008;47(4):784-8.
2008: Nielsen Hans Jørgen; Brünner Nils; Frederiksen Camilla; Lomholt Anne Fog; King Denis; Jørgensen Lars Nannestad; Olsen Jesper; Rahr Hans B; Thygesen Knud; Hoyer Ute; Laurberg Søren; Christensen Ib Jarle;
Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection.
Scandinavian journal of gastroenterology 2008;43(2):242-8.
2008: Sørensen Nanna Møller; Schrohl Anne Sofie; Jensen Vibeke; Christensen Ib Jarle; Nielsen Hans Jørgen; Brünner Nils
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
Scandinavian journal of gastroenterology 2008;43(2):186-91.
2008: Hetland Merete Lund; Christensen Ib Jarle; Lottenburger Tine; Johansen Julia Sidenius; Svendsen Mads Nordahl; Hørslev-Petersen Kim; Nielsen Lone; Nielsen Hans Jørgen
Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients.
Disease markers 2008;24(1):1-10.
2007: Høgdall Estrid V S; Christensen Lise; Høgdall Claus K; Blaakaer Jan; Gayther Simon; Jacobs Ian J; Christensen Ib Jarle; Kjaer Susanne K
Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Oncology reports 2007;18(5):1051-9.
2007: Ytting H; Christensen I J; Thiel S; Jensenius J C; Svendsen M N; Nielsen L; Lottenburger T; Nielsen H J
Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise.
Scandinavian journal of immunology 2007;66(4):458-64.
2007: Petri Anette Lykke; Høgdall Estrid; Engelholm Svend Aage; Christensen Ib Jarle; Kjaer Susanne Krüger; Høgdall Claus K
[Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?]
Ugeskrift for laeger 2007;169(33):2614-9.
2007: Høgdall Estrid V S; Christensen Lise; Kjaer Susanne K; Blaakaer Jan; Christensen Ib Jarle; Gayther Simon; Jacobs Ian J; Høgdall Claus K
Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Gynecologic oncology 2007;106(2):318-24.
2007: Sørensen Nanna M; Byström Per; Christensen Ib J; Berglund Ake; Nielsen Hans Jørgen; Brünner Nils; Glimelius Bengt
TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4117-22.
2007: Johansen Julia S; Brasso Klaus; Iversen Peter; Teisner Børge; Garnero Patrick; Price Paul A; Christensen Ib Jarle
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3244-9.
2007: Lomholt Anne F; Frederiksen Camilla B; Christensen Ib J; Brünner Nils; Nielsen Hans J
Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.
Clinica chimica acta; international journal of clinical chemistry 2007;380(1-2):128-32.
2007: Larsson Lars-Inge; Holck Susanne; Christensen Ib Jarle
Prognostic role of syncytin expression in breast cancer.
Human pathology 2007;38(5):726-31.
2007: Frederiksen C; Lykke J; Christensen Ib J; Brünner N; Nielsen H J
Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer.
Scandinavian journal of clinical and laboratory investigation 2007;67(5):545-52.
2006: Schrohl Anne-Sofie; Meijer-van Gelder Marion E; Holten-Andersen Mads N; Christensen Ib Jarle; Look Maxime P; Mouridsen Henning T; Brünner Nils; Foekens John A
Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7054-8.
2006: Svendsen Mads N; Ytting Henriette; Brünner Nils; Nielsen Hans J; Christensen Ib J
Preoperative concentrations of suPAR and MBL proteins are associated with the development of pneumonia after elective surgery for colorectal cancer.
Surgical infections 2006;7(5):463-71.
2006: Davidsen M L; Würtz S Ø; Rømer M U; Sørensen N M; Johansen S K; Christensen I J; Larsen J K; Offenberg H; Brünner N; Lademann U
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.
British journal of cancer 2006;95(8):1114-20.
2006: Begum Farah Diba; Høgdall Estrid V S; Riisbro Rikke; Christensen Ib Jarle; Engelholm Svend A; Jørgensen Morten; Pedersen Bent Nørgaard; Høgdall Claus K
Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC).
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2006;114(10):675-81.
2006: Bjerregaard B; Holck S; Christensen I J; Larsson L-I
Syncytin is involved in breast cancer-endothelial cell fusions.
Cellular and molecular life sciences : CMLS 2006;63(16):1906-11.
2006: Holten-Andersen Mads Nikolaj; Nielsen Hans Jørgen; Sørensen Steen; Jensen Vibeke; Brünner Nils; Christensen Ib Jarle
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2006;42(12):1889-96.
2006: Gronlund B; Høgdall E V S; Christensen I J; Johansen J S; Nørgaard-Pedersen B; Engelholm S A; Høgdall C
Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125).
The International journal of biological markers 2006;21(3):141-8.
2006: Bülow S; Bulut O; Christensen I J; Harling H;
Transanal stent in anterior resection does not prevent anastomotic leakage.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2006;8(6):494-6.
2006: Lund Leif R; Green Kirsty A; Stoop Allart A; Ploug Michael; Almholt Kasper; Lilla Jennifer; Nielsen Boye S; Christensen Ib J; Craik Charles S; Werb Zena; Danø Keld; Rømer John
Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
The EMBO journal 2006;25(12):2686-97.
2006: Petri Anette Lykke; Høgdall Estrid; Christensen Ib Jarle; Kjaer Susanne Krüger; Blaakaer Jan; Høgdall Claus Kim
Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2006;114(5):359-63.
2006: Ytting H; Christensen I J; Basse L; Lykke J; Thiel S; Jensenius J C; Nielsen H J
Influence of major surgery on the mannan-binding lectin pathway of innate immunity.
Clinical and experimental immunology 2006;144(2):239-46.
2006: Piironen Timo; Haese Alexander; Huland Hartwig; Steuber Thomas; Christensen Ib Jarle; Brünner Nils; Danø Keld; Høyer-Hansen Gunilla; Lilja Hans
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
Clinical chemistry 2006;52(5):838-44.
2006: Schmidt Henrik; Sorensen Boe S; Sjoegren Pia; Christensen Ib Jarle; Fode Kirsten; Larsen Jorn; Nexo Ebba; von der Maase Hans
Circulating tyrosinase and MART-1 mRNA does not independently predict relapse or survival in patients with AJCC stage I-II melanoma.
The Journal of investigative dermatology 2006;126(4):849-54.
2006: Brasso Klaus; Christensen Ib Jarle; Johansen Julia S; Teisner Børge; Garnero Patrick; Price Paul A; Iversen Peter
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma.
The Prostate 2006;66(5):503-13.
2006: Nygaard Ulrikka; Larsen Jacob; Kristensen Tim D; Wesenberg Finn; Jonsson Olafur G; Carlsen Niels T; Forestier Erik; Kirchhoff Maria; Larsen Jørgen K; Schmiegelow Kjeld; Christensen Ib J
Flow cytometric DNA index, G-band karyotyping, and comparative genomic hybridization in detection of high hyperdiploidy in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2006;28(3):134-40.
2006: Hammer J H; Basse L; Svendsen M N; Werther K; Brünner N; Christensen I J; Nielson H J
Impact of elective resection on plasma TIMP-1 levels in patients with colon cancer.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2006;8(3):168-72.
2006: Schmidt Henrik; Johansen Julia S; Sjoegren Pia; Christensen Ib J; Sorensen Boe S; Fode Kirsten; Larsen Jorn; von der Maase Hans
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):798-804.
2006: Pappot Helle; Pedersen Anders N; Brünner Nils; Christensen Ib J
The complex between urokinase (uPA) and its type-1 inhibitor (PAI-1) in pulmonary adenocarcinoma: relation to prognosis.
Lung cancer (Amsterdam, Netherlands) 2006;51(2):193-200.
2006: Holten-Andersen M N; Brünner N; Nielsen H J; Christensen I J; Sørensen N Møller; Rasmussen A S Schrohl; Primdahl H; Orntoft T
Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer.
The International journal of biological markers 2006;21(1):6-11.
2006: Møller Sørensen Nanna; Blincko Stuart; Dinsmore Emma; Weerakoon Ambika; Lally James; Jensen Vibeke; Nielsen Hans Jørgen; Christensen Ib Jarle; Rodgers Brian C; Dowell Barry; Brünner Nils; Davis Gerard
Evaluation of an improved tissue inhibitor of metalloproteinase 1 dual monoclonal sandwich immunoassay.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(6):319-28.
2005: Svendsen M N; Werther K; Christensen I J; Basse L; Nielsen H J
Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1).
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2005;54(11):458-63.
2005: Gronlund Bo; Christensen Ib J; Bülow-Lehnsby Anne Lene; Engelholm Svend A; Hansen Heine H; Høgdall Claus
Recurrent epithelial ovarian cancer: validation and improvement of an established prognostic index.
European journal of obstetrics, gynecology, and reproductive biology 2005;123(1):98-106.
2005: Rømer Maria Unni; Kirkebjerg Due Anne; Knud Larsen Jørgen; Hofland Kenneth Francis; Christensen Ib Jarle; Buhl-Jensen Peter; Almholt Kasper; Lerberg Nielsen Ole; Brünner Nils; Lademann Ulrik
Indication of a role of plasminogen activator inhibitor type I in protecting murine fibrosarcoma cells against apoptosis.
Thrombosis and haemostasis 2005;94(4):859-66.
2005: Nielsen Hans Jørgen; Christensen Ib Jarle; Brünner Nils Age
[Serological markers of colorectal cancer]
Ugeskrift for laeger 2005;167(44):4163-7.
2005: Schmidt H; Bastholt L; Geertsen P; Christensen I J; Larsen S; Gehl J; von der Maase H
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model.
British journal of cancer 2005;93(3):273-8.
2005: Pedersen Tanja Xenia; Pennington Caroline J; Almholt Kasper; Christensen Ib Jarle; Nielsen Boye Schnack; Edwards Dylan R; Rømer John; Danø Keld; Johnsen Morten
Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas.
Carcinogenesis 2005;26(7):1233-40.
2005: Würtz S Ø; Schrohl A-S; Sørensen N Møller; Lademann U; Christensen I J; Mouridsen H; Brünner N
Tissue inhibitor of metalloproteinases-1 in breast cancer.
Endocrine-related cancer 2005;12(2):215-27.
2005: Almasi Charlotte Elberling; Høyer-Hansen Gunilla; Christensen Ib Jarle; Danø Keld; Pappot Helle
Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue.
Lung cancer (Amsterdam, Netherlands) 2005;48(3):349-55.
2005: Larsen M B; Stephens R W; Brünner N; Nielsen H J; Engelholm L H; Christensen I J; Stetler-Stevenson W G; Høyer-Hansen G
Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients.
Scandinavian journal of immunology 2005;61(5):449-60.
2005: Lademann Ulrik; Rømer Maria U; Jensen Peter Buhl; Hofland Kenneth F; Larsen Lise; Christensen Ib Jarle; Brünner Nils
Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis.
European journal of cancer (Oxford, England : 1990) 2005;41(7):1095-100.
2005: Riisbro R; Christensen I J; Nielsen H J; Brünner N; Nilbert M; Fernebro E
Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration.
The International journal of biological markers 2005;20(2):93-102.
2005: Würtz Sidse Ørnbjerg; Christensen Ib Jarle; Schrohl Anne-Sofie; Mouridsen Henning; Lademann Ulrik; Jensen Vibeke; Brünner Nils
Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients.
Molecular & cellular proteomics : MCP 2005;4(4):483-91.
2005: Ytting Henriette; Christensen Ib Jarle; Jensenius Jens Christian; Thiel Steffen; Nielsen Hans Jørgen
Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer.
Cancer immunology, immunotherapy : CII 2005;54(3):265-72.
2005: Ytting Henriette; Christensen Ib Jarle; Thiel Steffen; Jensenius Jens Christian; Nielsen Hans Jørgen
Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(4):1441-6.
2005: Gronlund B; Lundvall L; Christensen I J; Knudsen J B; Høgdall C
Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(1):67-73.
2005: Bülow Steffen; Christensen Ib Jarle; Harling Henrik; Kronborg Ole; Fenger Claus; Nielsen Hans Jørgen;
[Local recurrence and survival after mesorectal excision for rectal cancer--secondary publication]
Ugeskrift for laeger 2005;167(4):401-3.
2005: Vind Ida; Vieira Ana; Hougs Lotte; Tavares Lourdes; Riis Lene; Andersen Paal Skytt; Locht Henning; Freitas Joao; Monteiro Estela; Christensen Ib Jarle; Munkholm Pia
NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls.
Digestion 2005;72(2-3):156-63.
2005: Svendsen M N; Lykke J; Werther K; Bisgaard T; Christensen I J; Nielsen H J
Bacterial antigen induced release of soluble vascular endothelial growth factor (VEGF) and VEGFR1 before and after surgery.
Scandinavian journal of clinical and laboratory investigation 2005;65(3):237-47.
2004: Johansen Julia S; Drivsholm Lars; Price Paul A; Christensen Ib Jarle
High serum YKL-40 level in patients with small cell lung cancer is related to early death.
Lung cancer (Amsterdam, Netherlands) 2004;46(3):333-40.
2004: Mortensen Kirsten; Christensen Ib Jarle; Nielsen Hans Jørgen; Hansen Ulla; Larsson Lars-Inge
High expression of endothelial cell nitric oxide synthase in peritumoral microvessels predicts increased disease-free survival in colorectal cancer.
Cancer letters 2004;216(1):109-14.
2004: Holten-Andersen Mads N; Fenger Claus; Nielsen Hans Jørgen; Rasmussen Anne-Sofie Schrohl; Christensen Ib Jarle; Brünner Nils; Kronborg Ole
Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2159-64.
2004: Gronlund Bo; Høgdall Claus; Christensen Ib J; Engelholm Svend A; Hansen Heine H
Is stabilization of disease a useful indicator for survival in second-line treatment of ovarian carcinoma pre-treated with Paclitaxel-Platinum?
Gynecologic oncology 2004;94(2):409-15.
2004: Riisbro R; Brünner N; Christensen I J; Nielsen H J
Soluble urokinase plasminogen activator receptor in blood transfusion components.
Transfusion medicine (Oxford, England) 2004;14(4):305-12.
2004: Larsen Jacob; Christensen Knud; Larsen Jørgen K; Jensen Peter Østrup; Gustavsson Ingemar; Christensen Ib Jarle
High resolution DNA flow cytometry of boar sperm cells in identification of boars carrying cytogenetic aberrations.
Theriogenology 2004;62(3-4):501-11.
2004: Ytting H; Jensenius J C; Christensen I J; Thiel S; Nielsen H J
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer.
Scandinavian journal of gastroenterology 2004;39(7):674-9.
2004: Holten-Andersen M; Christensen I J; Nilbert M; Bendahl P O; Nielsen H J; Brünner N; Fernebro E;
Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation study.
European journal of cancer (Oxford, England : 1990) 2004;40(1):64-72.
2004: Svendsen Mads N; Lykke Jakob; Werther Kim; Christensen Ib J; Nielsen Hans J
Concentrations of VEGF and VEGFR1 in paired tumor arteries and veins in patients with rectal cancer.
Oncology research 2004;14(11-12):611-5.
2003: Bülow S; Christensen I J; Harling H; Kronborg O; Fenger C; Nielsen H J;
Recurrence and survival after mesorectal excision for rectal cancer.
The British journal of surgery 2003;90(8):974-80.
2003: Johansen Julia S; Christensen Ib J; Riisbro Rikke; Greenall Michael; Han Chen; Price Paul A; Smith Kenneth; Brünner Nils; Harris Adrian L
High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.
Breast cancer research and treatment 2003;80(1):15-21.
2003: Schrohl Anne-Sofie; Christensen Ib Jarle; Pedersen Anders N; Jensen Vibeke; Mouridsen Henning; Murphy Gillian; Foekens John A; Brunner Nils; Holten-Andersen Mads Nikolaj
Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer.
Molecular & cellular proteomics : MCP 2003;2(3):164-72.
2003: Werther Kim; Sørensen Sten; Christensen Ib J; Nielsen Hans J;
Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(8):837-45.
2002: Nielsen H J; Christensen I J; Svendsen M N; Hansen U; Werther K; Brünner N; Petersen L J; Kristensen J K
Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2002;51(11):563-7.
2002: Nielsen H J; Christensen I J; Moesgaard F; Kehlet H;
Ranitidine as adjuvant treatment in colorectal cancer.
The British journal of surgery 2002;89(11):1416-22.
2002: Høgdall Claus K; Christensen Ib J; Stephens Ross W; Sørensen Steen; Nørgaard-Pedersen Bent; Nielsen Hans J
Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(9):630-8.
2002: Holten-Andersen Mads N; Christensen Ib Jarle; Nielsen Hans Jørgen; Lilja Hans; Murphy Gillian; Jensen Vibeke; Brünner Nils; Piironen Timo
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
Clinical chemistry 2002;48(8):1305-13.
2002: Cintin Christina; Johansen Julia S; Christensen Ib Jarle; Price Paul A; Sørensen Steen; Nielsen Hans Jørgen
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
Cancer 2002;95(2):267-74.
2002: Riisbro Rikke; Christensen Ib J; Piironen Timo; Greenall Michael; Larsen Berthe; Stephens Ross W; Han Cheng; Høyer-Hansen Gunilla; Smith Kenneth; Brünner Nils; Harris Adrian L
Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1132-41.
2002: Werther K; Christensen I J; Nielsen H J;
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
British journal of cancer 2002;86(3):417-23.
2002: Holten-Andersen Mads N; Christensen Ib Jarle; Nielsen Hans Jørgen; Stephens Ross W; Jensen Vibeke; Nielsen Ole Haagen; Sørensen Steen; Overgaard Jens; Lilja Hans; Harris Adrian; Murphy Gillian; Brünner Nils
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):156-64.
2002: Post Carolin; Christensen Ib Jarle; Flyger Henrik; Christiansen Jette; Larsen Jørgen K
Flow cytometric bivariate analysis of DNA and cytokeratin in colorectal cancer.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2002;24(4-5):113-24.
2002: Werther K; Christensen I J; Nielsen H J
Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
Scandinavian journal of clinical and laboratory investigation 2002;62(5):343-50.
2002: Holten-Andersen M N; Brunner N; Christensen I J; Jensen V; Nielsen H J
Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components.
Scandinavian journal of clinical and laboratory investigation 2002;62(3):223-30.
2001: Bülow S; Christensen I J
[Sigmoidoscopy as primary examination in patients with bowel symptoms]
Ugeskrift for laeger 2001;163(47):6573-6.
2001: Riisbro R; Stephens R W; Brünner N; Christensen I J; Nielsen H J; Heilmann L; von Tempelhoff G F
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Gynecologic oncology 2001;82(3):523-31.
2001: Werther K; Christensen I J; Nielsen H J;
The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.
The European journal of surgery = Acta chirurgica 2001;167(4):287-92.
2001: Fernebro E; Madsen R R; Fernö M; Brünner N; Bendahl P; Christensen I J; Johnson A; Nilbert M
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients.
European journal of cancer (Oxford, England : 1990) 2001;37(4):486-91.
2001: Frandsen T L; Holst-Hansen C; Nielsen B S; Christensen I J; Nyengaard J R; Carmeliet P; Brünner N
Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
Cancer research 2001;61(2):532-7.
2000: Pedersen A N; Christensen I J; Stephens R W; Briand P; Mouridsen H T; Danø K; Brünner N
The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival.
Cancer research 2000;60(24):6927-34.
2000: Holten-Andersen M N; Stephens R W; Nielsen H J; Murphy G; Christensen I J; Stetler-Stevenson W; Brünner N
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4292-9.
2000: Mynster T; Christensen I J; Moesgaard F; Nielsen H J
Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
The British journal of surgery 2000;87(11):1553-62.
2000: Werther K; Christensen I J; Brünner N; Nielsen H J
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(7):657-62.
2000: Lund L R; Bjørn S F; Sternlicht M D; Nielsen B S; Solberg H; Usher P A; Osterby R; Christensen I J; Stephens R W; Bugge T H; Danø K; Werb Z
Lactational competence and involution of the mouse mammary gland require plasminogen.
Development (Cambridge, England) 2000;127(20):4481-92.
2000: Nielsen H J; Christensen I J; Sørensen S; Moesgaard F; Brünner N
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.
Annals of surgical oncology 2000;7(8):617-23.
2000: Ottesen G L; Graversen H P; Blichert-Toft M; Christensen I J; Andersen J A
Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
Breast cancer research and treatment 2000;62(3):197-210.
2000: Rose C; Kamby C; Mouridsen H T; Andersson M; Bastholt L; Møller K A; Andersen J; Munkholm P; Dombernowsky P; Christensen I J
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Breast cancer research and treatment 2000;61(2):103-10.
2000: Ottesen G L; Christensen I J; Larsen J K; Larsen J; Baldetorp B; Linden T; Hansen B; Andersen J
Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
Breast cancer research and treatment 2000;60(3):219-26.
1999: Nielsen H J; Hansen U; Christensen I J; Reimert C M; Brünner N; Moesgaard F
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue.
The Journal of pathology 1999;189(4):487-95.
1999: Flyger H L; Larsen J K; Nielsen H J; Christensen I J
DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival.
Cytometry 1999;38(6):293-300.
1999: Holten-Andersen M N; Murphy G; Nielsen H J; Pedersen A N; Christensen I J; Høyer-Hansen G; Brünner N; Stephens R W
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
British journal of cancer 1999;80(3-4):495-503.
1999: Mortensen K; Holck S; Christensen I J; Skouv J; Hougaard D M; Blom J; Larsson L I
Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1093-7.
1999: Stephens R W; Nielsen H J; Christensen I J; Thorlacius-Ussing O; Sørensen S; Danø K; Brünner N
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.
Journal of the National Cancer Institute 1999;91(10):869-74.
1999: Cintin C; Johansen J S; Christensen I J; Price P A; Sørensen S; Nielsen H J
Serum YKL-40 and colorectal cancer.
British journal of cancer 1999;79(9-10):1494-9.
1999: Brünner N; Nielsen H J; Hamers M; Christensen I J; Thorlacius-Ussing O; Stephens R W
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1999;107(1):160-7.
1998: Sorensen M; Sehested M; Christensen I J; Larsen J K; Jensen P B
Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation.
British journal of cancer 1998;77(12):2152-61.
1998: Nielsen H J; Pappot H; Christensen I J; Brünner N; Thorlacius-Ussing O; Moesgaard F; Danø K; Grøndahl-Hansen J
Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer.
BMJ (Clinical research ed.) 1998;316(7134):829-30.
1997: Ottesen G L; Christensen I J; Larsen J K; Larsen J; Christiansen J; Baldetorp B; Linden T; Hansen B; Andersen J A
DNA ploidy analysis in breast carcinoma. Comparison of unfixed and fixed tissue analyzed by image and flow cytometry.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1997;19(5):413-22.
1997: Grøndahl-Hansen J; Christensen I J; Briand P; Pappot H; Mouridsen H T; Blichert-Toft M; Danø K; Brünner N
Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):233-9.
1997: Jensen P B; Holm B; Sorensen M; Christensen I J; Sehested M
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
British journal of cancer 1997;75(6):869-77.
1996: Ottesen G L; Christensen I J; Larsen J K; Hansen B; Andersen J A
Tissue disaggregation for flow cytometric DNA analysis: comparison of fine-needle aspiration and an automated mechanical procedure.
Cytometry 1996;26(1):65-8.
1996: Larsen J K; Møller U; Christensen I J; Christensen J
Circadian variation of DNA replication in hamster cheek pouch epithelium analysed by tritiated thymidine labelling, flow sorting and autoradiography: no resting S phase cells in the normal epithelium.
Cell proliferation 1996;29(2):61-71.
1995: Ottesen G L; Christensen I J; Larsen J K; Kerndrup G B; Hansen B; Andersen J A
DNA aneuploidy in early breast cancer.
British journal of cancer 1995;72(4):832-9.
1995: Ottesen G L; Christensen I J; Larsen J K; Christiansen J; Hansen B; Andersen J A
DNA analysis of in situ ductal carcinoma of the breast via flow cytometry.
Cytometry 1995;22(3):168-76.
1995: Ottesen G L; Christensen I J; Larsen J K; Hansen B; Andersen A J
Flow cytometric DNA analysis of breast cancers with predominance of carcinoma in situ: a comparison of the premalignant and malignant components.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(8):881-8.
1995: Larsen J K; Christensen I J; Kieler J
Cell cycle perturbation by sodium butyrate in tumorigenic and non-tumorigenic human urothelial cell lines assessed by flow cytometric bromodeoxyuridine/DNA analysis.
Cell proliferation 1995;28(7):359-71.
1995: Vindeløv L L; Christensen I J; Engelholm S A; Guldhammer B H; Højgaard K; Sørensen B L; Wolf H
Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas.
Cytometry 1995;22(2):93-102.
1995: Romain S; Christensen I J; Chinot O; Balslev I; Rose C; Martin P M; Thorpe S M
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer.
International journal of cancer. Journal international du cancer 1995;61(1):7-12.
1994: Jensen P O; Larsen J K; Christensen I J; van Erp P E
Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
Cytometry 1994;15(2):154-61.
1994: Balslev I; Christensen I J; Rasmussen B B; Larsen J K; Lykkesfeldt A E; Thorpe S M; Rose C; Briand P; Mouridsen H T
Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer.
International journal of cancer. Journal international du cancer 1994;56(1):16-25.
1994: Pedersen L; Larsen J K; Christensen I J; Lykkesfeldt A; Holck S; Schiødt T
DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.
Breast cancer research and treatment 1994;29(3):297-306.
1994: Vindeløv L L; Christensen I J
Detergent and proteolytic enzyme-based techniques for nuclear isolation and DNA content analysis.
Methods in cell biology 1994;41():219-29.
1993: Grøndahl-Hansen J; Christensen I J; Rosenquist C; Brünner N; Mouridsen H T; Danø K; Blichert-Toft M
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.
Cancer research 1993;53(11):2513-21.
1993: Jensen P B; Christensen I J; Sehested M; Hansen H H; Vindeløv L
Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
British journal of cancer 1993;67(2):311-20.
1992: Carlsen N L; Ornvold K; Christensen I J; Laursen H; Larsen J K
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.
Virchows Archiv. A, Pathological anatomy and histopathology 1992;420(5):411-8.
1992: Jensen P B; Roed H; Sehested M; Demant E J; Vindeløv L; Christensen I J; Hansen H H
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
Cancer chemotherapy and pharmacology 1992;31(1):46-52.
1991: Larsen J K; Christensen I J; Christiansen J; Mortensen B T
Washless double staining of unfixed nuclei for flow cytometric analysis of DNA and a nuclear antigen (Ki-67 or bromodeoxyuridine).
Cytometry 1991;12(5):429-37.
1991: Frentz G; Møller U; Hölmich P; Christensen I J
On circadian rhythms in human epidermal cell proliferation.
Acta dermato-venereologica 1991;71(1):85-7.
1990: Ornvold K; Carstensen H; Larsen J K; Christensen I J; Ralfkiaer E
Flow cytometric DNA analysis of lesions from 18 children with langerhans cell histiocytosis (histiocytosis x).
The American journal of pathology 1990;136(6):1301-7.
1990: Mejer J N; Mortensen B T; Christensen I J
Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.
Medical oncology and tumor pharmacotherapy 1990;7(1):25-9.
1990: Vindeløv L L; Christensen I J
A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis.
Cytometry 1990;11(7):753-70.
1990: Vindeløv L; Christensen I J
An integrated set of methods for routine flow cytometric DNA analysis.
Methods in cell biology 1990;33():127-37.
1989: Thorpe S M; Rochefort H; Garcia M; Freiss G; Christensen I J; Khalaf S; Paolucci F; Pau B; Rasmussen B B; Rose C
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Cancer research 1989;49(21):6008-14.
1989: Jensen P B; Roed H; Vindeløv L; Christensen I J; Hansen H H
Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines.
Investigational new drugs 1989;7(4):307-15.
1988: Roed H; Vindeløv L L; Christensen I J; Spang-Thomsen M; Hansen H H
The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay.
European journal of cancer & clinical oncology 1988;24(2):247-53.
1988: Lykkesfeldt A E; Balslev I; Christensen I J; Larsen J K; Mølgaard H; Rasmussen B B; Thorpe S; Rose C
DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease.
Acta oncologica (Stockholm, Sweden) 1988;27(6A):749-56.
1987: Roed H; Vindelov L L; Christensen I J; Spang-Thomsen M; Hansen H H
The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.
Cancer chemotherapy and pharmacology 1987;19(1):16-20.
1987: Roed H; Vindeløv L L; Spang-Thomsen M; Christensen I J; Hansen H H
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.
Cancer chemotherapy and pharmacology 1987;19(4):315-8.
1985: Larsen J K; Frentz G; Møller U; Christensen I J
A method for flow cytometric cell cycle analysis of normal and psoriatic human epidermis based on a detergent/citric acid technique for suspension of nuclei.
Virchows Archiv. B, Cell pathology including molecular pathology 1985;48(3):247-59.
1984: Møller U; Larsen J K; Keiding N; Christensen I J
Circadian-stage dependence of methotrexate in a keratinized epithelium. An in-vivo study using flow cytometry on the hamster cheek pouch epithelium.
Cell and tissue kinetics 1984;17(5):483-95.
1983: Søndergaard K; Larsen J K; Møller U; Christensen I J; Hou-Jensen K
DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course.
Virchows Archiv. B, Cell pathology including molecular pathology 1983;42(1):43-52.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ib Jarle Christensen

Research Profile (preview)

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ib Jarle Christensen (preview)

All Publications